175 related articles for article (PubMed ID: 33850301)
1. IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children.
Prokunina-Olsson L; Morrison RD; Obajemu A; Mahamar A; Kim S; Attaher O; Florez-Vargas O; Sidibe Y; Onabajo OO; Hutchinson AA; Manning M; Kwan J; Brand N; Dicko A; Fried M; Albert PS; Mbulaiteye SM; Duffy PE
Genes Immun; 2021 May; 22(1):44-55. PubMed ID: 33850301
[TBL] [Abstract][Full Text] [Related]
2. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
4. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
[TBL] [Abstract][Full Text] [Related]
5.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
6. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
7. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
8. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
Front Immunol; 2021; 12():692263. PubMed ID: 34497603
[No Abstract] [Full Text] [Related]
10. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
Obajemu AA; Rao N; Dilley KA; Vargas JM; Sheikh F; Donnelly RP; Shabman RS; Meissner EG; Prokunina-Olsson L; Onabajo OO
J Immunol; 2017 Dec; 199(11):3808-3820. PubMed ID: 29070670
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
[TBL] [Abstract][Full Text] [Related]
12. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
14. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
[TBL] [Abstract][Full Text] [Related]
15. Functional genetic variants of the IFN-λ3 (IL28B) gene and transcription factor interactions on its promoter.
Roy S; Guha Roy D; Bhushan A; Bharatiya S; Chinnaswamy S
Cytokine; 2021 Jun; 142():155491. PubMed ID: 33725487
[TBL] [Abstract][Full Text] [Related]
16. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
Bharatiya S; Agarwal A; Chinnaswamy S
J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
[TBL] [Abstract][Full Text] [Related]
17. IFN-λ4: the paradoxical new member of the interferon lambda family.
O'Brien TR; Prokunina-Olsson L; Donnelly RP
J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
[TBL] [Abstract][Full Text] [Related]
18. Gender-dependent multiple cross-phenotype association of interferon lambda genetic variants with peripheral blood profiles in healthy individuals.
Roy DG; Singh L; Chaturvedi HK; Chinnaswamy S
Mol Genet Genomic Med; 2024 Jan; 12(1):e2292. PubMed ID: 37795763
[TBL] [Abstract][Full Text] [Related]
19. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
20. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
Lu YF; Goldstein DB; Urban TJ; Bradrick SS
Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]